These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coronary Artery Disease - Eighth International Congress. From prevention to intervention. Wong NC IDrugs; 2009 Dec; 12(12):742-6. PubMed ID: 19943213 [TBL] [Abstract][Full Text] [Related]
4. Why So Few New Cardiovascular Drugs Translate to the Clinics. Vatner SF Circ Res; 2016 Sep; 119(6):714-7. PubMed ID: 27587410 [TBL] [Abstract][Full Text] [Related]
5. A report from the European Society of Cardiology Congress 2013 (August 31-September 4, 2013 - Amsterdam, the Netherlands). Rabasseda X Drugs Today (Barc); 2013 Sep; 49(9):575-91. PubMed ID: 24086953 [TBL] [Abstract][Full Text] [Related]
6. A new feature for Cardiology in Review. Frishman WH; O'Gara PT Cardiol Rev; 2012; 20(3):101. PubMed ID: 22370772 [No Abstract] [Full Text] [Related]
7. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain. Wong NC IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849 [TBL] [Abstract][Full Text] [Related]
8. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 1. Kirkham K IDrugs; 2009 Jan; 12(1):5-6. PubMed ID: 19127494 [No Abstract] [Full Text] [Related]
9. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 2. Kirkham K IDrugs; 2009 Jan; 12(1):7-9. PubMed ID: 19127495 [No Abstract] [Full Text] [Related]
12. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Cai H; Griendling KK; Harrison DG Trends Pharmacol Sci; 2003 Sep; 24(9):471-8. PubMed ID: 12967772 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of chalcones as cardiovascular agents. Mahapatra DK; Bharti SK Life Sci; 2016 Mar; 148():154-72. PubMed ID: 26876916 [TBL] [Abstract][Full Text] [Related]
14. Latest advances and research in stroke: Focus on diagnostic and therapeutic targets. Montaner J Drug News Perspect; 2006 Apr; 19(3):173-83. PubMed ID: 16804570 [TBL] [Abstract][Full Text] [Related]
16. Light and Dark of Reactive Oxygen Species for Vascular Function: 2014 ASVB (Asian Society of Vascular Biology). Shimokawa H; Satoh K J Cardiovasc Pharmacol; 2015 May; 65(5):412-8. PubMed ID: 25162437 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular research in Australia. Doggrell SA Drug News Perspect; 2003 Oct; 16(8):540-50. PubMed ID: 14668952 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of sphingosine-1-phosphate (S1P). Levkau B Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656 [TBL] [Abstract][Full Text] [Related]